Clinical Trials Browser

Phase 2 × OTHER × reolysin × Clear all

NCT03723915 2022-10-05

Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Phase 2 Terminated

17 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms